By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > England Reports Sharp Rise in Lyme Disease Cases Amid Expanding Tick Populations

England Reports Sharp Rise in Lyme Disease Cases Amid Expanding Tick Populations

GMJ
Last updated: 29/06/2026 13:07
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Chart showing rising Lyme disease case numbers in England with tick illustration
Laboratory-confirmed Lyme disease cases in England jumped 22% to 1,168 in 2025, driven by expanding tick populations and environmental changes. The UK Health Security Agency reports the disease remains the country's most common locally acquired vector-borne infection. — Photo by Erik Karits on Pexels (Pexels License)
SHARE
1 min read|135 words

The UK Health Security Agency has documented a significant surge in Lyme disease transmission across England, with confirmed cases rising 22% from 959 in 2024 to 1,168 in 2025. This marked increase reflects expanding tick populations and their increasingly widespread distribution throughout the UK, driven by environmental factors including climate patterns, habitat modifications, and changes in host animal populations.

Lyme disease, caused by the bacterium Borrelia burgdorferi, continues to represent England’s most common locally acquired vector-borne infection. The UKHSA notes that while peak tick activity traditionally occurs during warmer months, transmission risk now persists year-round, representing a notable departure from historical seasonal patterns. Healthcare providers are advised to maintain heightened clinical awareness for early recognition of Lyme disease presentations, as prompt antibiotic treatment initiated within weeks of symptom onset provides optimal therapeutic outcomes.

Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Lyme disease cases surge 22% in England as tick populations expand →

Related reference
  • Iron · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Corrected Global Data on Substance Use Burden Across 204 Countries Reveals Shifting Patterns

Nature Medicine has published a corrected Global Burden of Disease assessment of…

Engineered Heart Muscle From Stem Cells Shows Promise in First-in-Human Trial

A first-in-human clinical trial of engineered heart muscle derived from induced pluripotent…

Most People Who Stop GLP-1 Drugs Like Ozempic Eventually Return to Treatment

A new analysis of treatment patterns shows that many patients who discontinue…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

PHEIC Declaration: Ebola Outbreak Cross-Border Transmission DRC-Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Global HealthPolicy & Systems

WHO Declares Public Health Emergency as Ebola Crosses DRC-Uganda Border

By
Prof. Giorgi Pkhakadze
31/05/2026
Medical illustration showing laser treatment targeting retinal cells in age-related macular degeneration

Finnish Researchers Develop Preventive Laser Therapy for Dry Age-Related Macular Degeneration

By
Prof. Giorgi Pkhakadze
04/06/2026
CoQ10 supplement comparison chart showing bioavailability differences between formulations

Manufacturing Process, Not Molecular Form, Drives CoQ10 Bioavailability

By
Prof. Giorgi Pkhakadze
03/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up